16 reports of this reaction
1.5% of all ASPIRIN 81MG reports
#17 most reported adverse reaction
GASTROINTESTINAL HAEMORRHAGE is the #17 most commonly reported adverse reaction for ASPIRIN 81MG, manufactured by Allegiant Health. There are 16 FDA adverse event reports linking ASPIRIN 81MG to GASTROINTESTINAL HAEMORRHAGE. This represents approximately 1.5% of all 1,051 adverse event reports for this drug.
Patients taking ASPIRIN 81MG who experience gastrointestinal haemorrhage should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
GASTROINTESTINAL HAEMORRHAGE is a less commonly reported adverse event for ASPIRIN 81MG, but still significant enough to appear in the safety profile.
In addition to gastrointestinal haemorrhage, the following adverse reactions have been reported for ASPIRIN 81MG:
The following drugs have also been linked to gastrointestinal haemorrhage in FDA adverse event reports:
GASTROINTESTINAL HAEMORRHAGE has been reported as an adverse event in 16 FDA reports for ASPIRIN 81MG. This does not prove causation, but indicates an association observed in post-market surveillance data.
GASTROINTESTINAL HAEMORRHAGE accounts for approximately 1.5% of all adverse event reports for ASPIRIN 81MG, making it a notable side effect.
If you experience gastrointestinal haemorrhage while taking ASPIRIN 81MG, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.